ACHV Q2 2025 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

ACHVAchieve Life Sciences, Inc.

$233M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$13M

Net Income

-$13M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$59M

Total Liabilities

$17M

Stockholders' Equity

$42M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$13M	-$8M	-49.0%
Net Income	-$13M	-$8M	-50.3%